Sandeep Maruti Bagul

Title: Sandeep Maruti Bagul: Innovator in Pharmaceutical Chemistry

Introduction

Sandeep Maruti Bagul is a notable inventor based in Navi Mumbai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Sandeep holds a patent for Styrenyl 1,2,4-oxadiazole compounds. This invention relates to oxadiazole compounds in all their stereoisomeric and tautomeric forms and mixtures thereof in all ratios. It also encompasses their pharmaceutically acceptable salts, solvates, prodrugs, and polymorphs. The invention details processes for manufacturing these oxadiazole compounds and pharmaceutical compositions containing them. These compounds are particularly useful in the treatment of cancer, especially chronic myeloid leukemia (CML). Furthermore, the invention provides a method for treating cancer by administering a therapeutically effective amount of these compounds or their pharmaceutical compositions to a mammal in need.

Career Highlights

Sandeep is currently associated with Piramal Enterprises Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has led to advancements that could significantly impact cancer treatment.

Collaborations

Sandeep collaborates with talented professionals such as Meenakshi Sivakumar and Ankush Gangaram Sarde, contributing to a dynamic research environment.

Conclusion

Sandeep Maruti Bagul's work exemplifies the intersection of innovation and healthcare, showcasing the potential of his patented compounds in the fight against cancer. His contributions are paving the way for future advancements in pharmaceutical chemistry.